ARCHIVES

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Official Outlines agency’s Views On Efficacy Requirement

June 16, 1999

NCI Study Fails To Support Finding Of Excess Cancer In Utah Nuclear Fallout Areas

January 23, 1987

Clinical Trials Approved By NCI’s CTEP Listed

February 25, 2005

Science Agencies Seek To Measure Effect Of Research Funding

June 4, 2010

NCI Adds $700,000 to CCOP Budget, Makes Four New Awards

June 9, 1989

Decisively Positive Swedish Study of PSA Becomes Focus of Debate Over Screening

October 28, 2011